* Quipt Home Medical Corp QIPT.V is expected to report
results on February 28 (estimated).
* The Wilder Kentucky-based company is expected to report
revenue
of $27.977 million, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Quipt Home Medical
Corp
is for a loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $9.25, about 43.2% above its last closing
price of $5.25.
*
This summary was machine generated January 28 at 14:23 GMT. All
figures in US dollars unless otherwise stated